80074-34-6

Basic information

• Product Name: Benzoic acid, 2-ethoxy-5-nitro-, methyl ester
• CAS NO: 80074-34-6
• Molecular Formula: C10H11NO5
• Molecular Weight: 225.201
• Mol File: 80074-34-6.mol
• Article Data: 9

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 2-ethoxy-5-nitro-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 2-ethoxy-5-nitro-, methyl ester(80074-34-6)
• EPA Substance Registry System: Benzoic acid, 2-ethoxy-5-nitro-, methyl ester(80074-34-6)

Safety Data

• Hazardous Substances Data: 80074-34-6(Hazardous Substances Data)

Upstream product

• 69-72-7 salicylic acid 
• 74-96-4 ethyl bromide 
• 17302-46-4 methyl 2-hydroxy-5-nitrobenzoate 
• 75-03-6 ethyl iodide 
• 96-97-9 5-nitrosalicylic acid 
• 64-17-5 ethanol 

Downstream Products

• 920739-92-0 2-ethoxy-5-nitro-N-hydroxybenzamide 
• 1356451-86-9 C₂₀H₁₇N₃O₅S 
• 920739-81-7 5-amino-2-ethoxy-N-hydroxybenzamide 

Relevant articles and documents

MODIFIED PROTEINS AND PROTEIN DEGRADERS

Provided herein are compounds, pharmaceutical compositions, and methods for binding or degrading target proteins. Further provided herein are compounds having a DNA damage-binding protein 1 (DDB1) binding moiety. Some such embodiments include a linker. Some such embodiments include a target protein binding moiety. Further provided herein are ligand-DDB1 complexes. Further provided herein are in vivo modified DDB1 proteins.

Novel substituted sulfamide compound, preparation method and application thereof as PTP1B inhibitor

The invention relates to a novel substituted sulfamide compound of a structure of a formula I as shown in the description, a pharmaceutically acceptable salt of the novel substituted sulfamide compound, a preparation method, and relates to a medicinal composition comprising the compound of the formula I or a pharmaceutically acceptable salt of the compound. The compound of the formula I or the pharmaceutically acceptable salt of the compound has activity of inhibiting protein tyrosine phosphatase 1B (PTP1B), so that the compound or the pharmaceutically acceptable salt of the compound has an application of preparing a medicine for preventing/treating symptoms or diseases such as hyperglycemia and type-2 diabetes.

5-[3-(2,5-diethoxy-4-methylsulfonyl-benzyl)-ureido]-2-ethoxylmethyl benzoate new compound and preparation method and application thereof

The invention provides a new compound. The name of the compound is 5-[3-(2,5-diethoxy-4-methylsulfonyl-benzyl)-ureido]-2-ethoxylmethyl benzoate; molecular weight of the compound is 509.5; and structure of the compound is as shown in the structural formula (compound 1). Meanwhile, the invention provides a preparation method of the compound 1. The compound provided by the invention has good drug-likeness and can be used in the research field of new drugs, especially in the research field of type-II diabetes innovative drugs.